CLINICAL_TRIALS ClinicalTrials.gov record update

Naltrexone Randomized Controlled Trial for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02137252
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:24.623292+00:00
Published At: 2021-11-16T00:00:00+00:00
Record Updated At: 2021-11-16
Results Posted At: 2021-11-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Invasive Breast Cancer (Stage I-III)", "Ductal Carcinoma in Situ", "Lobular Carcinoma in Situ", "Lobular Carcinoma", "Fatigue Related to Cancer Treatment"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-11-16"
protocolSection.identificationModule.nctId: "NCT02137252"
protocolSection.identificationModule.officialTitle: "Naltrexone Randomized Controlled Trial for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-11-16"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.